REVB
REVELATION BIOSCIENCES, INC.Company Information
- Company Name
- REVELATION BIOSCIENCES, INC.
- CIK
- CIK0001810560
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- REVB: Nasdaq, REVBW: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- REVB
SEC filing data through
Insider Sentiment
- Last purchase
- 2023-04-18
- Last sale
- 2023-12-08
- Shares purchased (TTM)
- 25,000
- Shares sold (TTM)
- 35,045
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 287,294
- Shares outstanding
- 3,829,363
- Ownership
- 7.50%
Earnings Market Reaction
- Filing date
- 2026-08-06
- Price on filing date
- —
- 1-month reaction
- -6.25%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 11 | 14 | 11 | 13 | 5 | 4 | 6 | 7 | 12 | 15 | 12 | 14 | ||||||
| Deferred Offering Costs | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets Current | 12 | 14 | 11 | 13 | 5 | 4 | 7 | 7 | 12 | 15 | 12 | 14 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | 1 | 1 | 1 | - | - | - | 0 | - | - | - | - | - | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | - | - | - | 0 | - | - | - | - | - | ||||||
| Assets | 12 | 15 | 12 | 13 | 5 | 4 | 7 | 7 | 12 | 15 | 12 | 14 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 2 | 1 | 1 | ||||||
| Accrued Liabilities Current | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 8 | 1 | 1 | 1 | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | - | - | - | 0 | - | - | - | - | - | ||||||
| Liabilities Current | 2 | 1 | 2 | 2 | 2 | 1 | 2 | 4 | 11 | 5 | 6 | 5 | ||||||
| Operating Lease Liability Noncurrent | 1 | 1 | 1 | - | - | - | 0 | - | - | - | - | - | ||||||
| Liabilities | 2 | 2 | 3 | 2 | 2 | 1 | 2 | 4 | 11 | 5 | 6 | 5 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 66 | 65 | 58 | 58 | 49 | 45 | 45 | 41 | 38 | 38 | 32 | 32 | ||||||
| Retained Earnings Accumulated Deficit | -56 | -52 | -49 | -47 | -45 | -43 | -41 | -39 | -37 | -28 | -25 | -23 | ||||||
| Stockholders Equity | 10 | 13 | 9 | 11 | 4 | 3 | 5 | 3 | 1 | 9 | 7 | 9 | ||||||
| Liabilities And Stockholders Equity | 12 | 15 | 12 | 13 | 5 | 4 | 7 | 7 | 12 | 15 | 12 | 14 | ||||||
| Preferred Stock Par Or Stated Value Per Share | - | - | - | - | - | - | - | - | - | - | 0.00 | 0.00 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | ||||||
| Common Stock Shares Issued | 4 | 4 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Shares Outstanding | 4 | 4 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialREVELATION BIOSCIENCES, INC. (REVB) — SEC Financial Statements & Analysis
REVELATION BIOSCIENCES, INC. (REVB) is a pharmaceutical preparations company, incorporated in DE. REVELATION BIOSCIENCES, INC. trades on Nasdaq as: REVB, REVBW. REVELATION BIOSCIENCES, INC. (REVB)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06. Based on that filing, REVELATION BIOSCIENCES, INC. carries a market cap of $3.94M, a P/E ratio of -0.24x, a P/B ratio of 0.39x, an enterprise value of $-7.54M, and an EV/EBITDA multiple of 0.67x. On profitability, it posts a Return on Equity (ROE) of -236.56% and a Return on Assets (ROA) of -183.67%. Per share, it reports EPS of $-4.29, diluted EPS of $-4.29, free cash flow per share of $-2.47, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of 94.17% year-over-year and EPS growth of -89.82% year-over-year. On the balance sheet, it maintains a current ratio of 6.21x, a quick ratio of 6.11x, working capital of $9.80M, a debt-to-equity ratio of 0.24x, a debt ratio of 0.19, free cash flow of $-9.44M (TTM), and net debt of $-11.48M. Figures sourced from SEC EDGAR.
- Market Cap
- $3.94M
- P/E TTM
- -0.24x
- EPS TTM
- $-4.29
- P/B TTM
- 0.39x
- ROE TTM
- -236.56%
- ROA TTM
- -183.67%
- Debt To Equity
- 0.24x
- Free Cash Flow TTM
- $-9.44M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is REVELATION BIOSCIENCES, INC. in?
REVELATION BIOSCIENCES, INC. (REVB) operates in the Pharmaceutical Preparations industry.
What exchange does REVB trade on?
REVELATION BIOSCIENCES, INC. (REVB) trades on the Nasdaq.
Where is REVELATION BIOSCIENCES, INC. incorporated?
REVELATION BIOSCIENCES, INC. is incorporated in DE.
When was REVELATION BIOSCIENCES, INC. (REVB)'s most recent SEC filing?
REVELATION BIOSCIENCES, INC. (REVB)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06.
What is REVB's market cap?
REVELATION BIOSCIENCES, INC. (REVB) has a market capitalization of $3.94M as of 2026-06-30.
What is REVB's EPS (earnings per share)?
REVELATION BIOSCIENCES, INC. (REVB)'s trailing twelve month EPS is $-4.29 as of 2026-06-30.
What is REVB's ROE (return on equity)?
REVELATION BIOSCIENCES, INC. (REVB)'s trailing twelve month Return on Equity (ROE) is -236.56% as of 2026-06-30.
What is REVB's ROA (return on assets)?
REVELATION BIOSCIENCES, INC. (REVB)'s trailing twelve month Return on Assets (ROA) is -183.67% as of 2026-06-30.
What is REVB's EV/EBITDA?
REVELATION BIOSCIENCES, INC. (REVB)'s trailing twelve month EV/EBITDA is 0.67x as of 2026-06-30.